SIGLEC7 and colorectal carcinoma: It was recently reported that Siglec−7 is expressed in macrophages in CRC tissue from patients and that high levels of Siglec−7 expression in tumour tissues are associated with shorter overall survival in patients treated with immunotherapy for metastatic CRC (68).